Iranian South Medical Journal最新文献

英文中文

Molecular Detection of Epstein-Barr virus in Biopsy Samples of Patients Suffering from Bladder Cancer in Bushehr Province, Iran 伊朗布什尔省癌症膀胱患者活检标本中EB病毒的分子检测

Iranian South Medical Journal

Pub Date : 2022-12-01 DOI: 10.52547/ismj.25.4.326

R. Taherkhani, M. Farzaneh, S. Taherkhani, A. Amini, Faeazeh Keshtkar, Maryam Aghasipour, Arezoo Badri, Zahra Anaei, F. Farshadpour

引用次数: 1

Nuclear Imaging in Patients with Differentiated Thyroid Cancer and Negative Radioactive Io-dine Scan 分化型甲状腺癌患者的核成像与放射性碘扫描阴性

Iranian South Medical Journal

Pub Date : 2022-12-01 DOI: 10.52547/ismj.25.4.394

Alireza Emami-Ardekani, Najme Karamzade-Ziarati, Yalda Salehi, Rehaneh Manafi-Farid, A. Fard-Esfahani, P. Geramifar, D. Beiki, M. Akhlaghi, B. Fallahi

引用次数: 0

Evaluation of Antioxidant and Cytotoxic Activi-ty of Spirulina Platensis Ethanolic Extract 螺旋藻乙醇提取物的抗氧化和细胞毒性评价

Iranian South Medical Journal

Pub Date : 2022-12-01 DOI: 10.52547/ismj.25.4.285

Anies karimi, S. Akbarzadeh, A. Movahed, Hajar Jaberie

引用次数: 1

The Effect of Provincial Policies on the COVID-19 Mortality Rate: Risk Analysis Study in Hamadan Province 省政策对新冠肺炎死亡率的影响：哈马丹省的风险分析研究

Iranian South Medical Journal

Pub Date : 2022-12-01 DOI: 10.52547/ismj.25.4.340

Roya Ahmaddoost-rozdari, H. Mahjub, J. Poorolajal, A. Soltanian

Background: Governments adopt different policies and strategies to control and reduce the mortality rate of COVID-19. In order to investigate the effect of the adopted policies on the reduction of mortality caused by this disease, the policies implemented by the Regional Headquarter for the Control of COVID-19 Epidemic in Hamedan Province were evaluated. Materials and Methods: The required information was obtained from the Vice-Chancellor of Health of Hamadan University of Medical Sciences and the minutes of the meetings of the Headquarter for the Control of COVID-19 Epidemic in Hamadan Governorate. All the information obtained dates to the period from April to August 2021. A Bayesian network model was used in GeNIe software version 2.2 for the analysis of the information. Results: In this study, seven models were used to evaluate the impact of the adopted strategies. The first model included social distancing, including travel restriction and limiting gatherings, and the mortality rate was estimated to reach 4.72% by implementing the model. The second model includes observing personal hygiene, wearing masks, and vaccination, and the mortality rate was estimated to reach 4.92% by its implementation. The third model encompassed both travel restrictions and business closures, and the mortality rate reached 6.41% after its implementation. Models 4, 5, and 6, which are a combination of the first, second, and third models, have estimated the mortality rate to reach 1.95%, 2.77%, and 2.26%, respectively. In addition, model 7, which combines the above conditions, made the mortality rate reach 2.35%. In the present study, model 6 was selected as the most suitable model with five policies and RMES=0.03005. Conclusion: According to the results obtained in this study, the simultaneous implementation of five policies, including travel restrictions, business closures, personal hygiene, wearing masks and vaccination, can greatly reduce the risk of mortality. © 2022, Bushehr University of Medical Sciences. All rights reserved.

背景：各国政府采取不同的政策和战略来控制和降低新冠肺炎的死亡率。为了调查所采取的政策对降低该疾病造成的死亡率的影响，对哈梅丹省新冠肺炎疫情控制地区总部实施的政策进行了评估。材料和方法：所需信息来自哈马丹医科大学卫生副校长和哈马丹省新冠肺炎疫情控制总部会议记录。获得的所有信息的日期均为2021年4月至8月。GeNIe软件2.2版中使用了贝叶斯网络模型来分析信息。结果：在本研究中，使用了七个模型来评估所采取策略的影响。第一个模型包括保持社交距离，包括旅行限制和限制聚会，通过实施该模型，死亡率估计达到4.72%。第二种模式包括遵守个人卫生、戴口罩和接种疫苗，到实施时，死亡率估计达到4.92%。第三种模式包括旅行限制和企业关闭，实施后死亡率达到6.41%。模型4、5和6是第一、第二和第三个模型的组合，估计死亡率分别达到1.95%、2.77%和2.26%。此外，结合上述条件的模型7使死亡率达到2.35%。在本研究中，模型6被选为最合适的模型，有五种政策，RMES=0.03005。结论：根据本研究获得的结果，同时实施旅行限制、停业、个人卫生、戴口罩和接种疫苗等五项政策，可以大大降低死亡风险。©2022，布什尔医学科学大学。保留所有权利。

{"title":"The Effect of Provincial Policies on the COVID-19 Mortality Rate: Risk Analysis Study in Hamadan Province","authors":"Roya Ahmaddoost-rozdari, H. Mahjub, J. Poorolajal, A. Soltanian","doi":"10.52547/ismj.25.4.340","DOIUrl":"https://doi.org/10.52547/ismj.25.4.340","url":null,"abstract":"Background: Governments adopt different policies and strategies to control and reduce the mortality rate of COVID-19. In order to investigate the effect of the adopted policies on the reduction of mortality caused by this disease, the policies implemented by the Regional Headquarter for the Control of COVID-19 Epidemic in Hamedan Province were evaluated. Materials and Methods: The required information was obtained from the Vice-Chancellor of Health of Hamadan University of Medical Sciences and the minutes of the meetings of the Headquarter for the Control of COVID-19 Epidemic in Hamadan Governorate. All the information obtained dates to the period from April to August 2021. A Bayesian network model was used in GeNIe software version 2.2 for the analysis of the information. Results: In this study, seven models were used to evaluate the impact of the adopted strategies. The first model included social distancing, including travel restriction and limiting gatherings, and the mortality rate was estimated to reach 4.72% by implementing the model. The second model includes observing personal hygiene, wearing masks, and vaccination, and the mortality rate was estimated to reach 4.92% by its implementation. The third model encompassed both travel restrictions and business closures, and the mortality rate reached 6.41% after its implementation. Models 4, 5, and 6, which are a combination of the first, second, and third models, have estimated the mortality rate to reach 1.95%, 2.77%, and 2.26%, respectively. In addition, model 7, which combines the above conditions, made the mortality rate reach 2.35%. In the present study, model 6 was selected as the most suitable model with five policies and RMES=0.03005. Conclusion: According to the results obtained in this study, the simultaneous implementation of five policies, including travel restrictions, business closures, personal hygiene, wearing masks and vaccination, can greatly reduce the risk of mortality. © 2022, Bushehr University of Medical Sciences. All rights reserved.","PeriodicalId":14583,"journal":{"name":"Iranian South Medical Journal","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46440781","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

The in vitro and in silico Anticholinesterase Ac-tivities of Brittle Star (Ophiocoma erinaceus) crude venoms from the Persian Gulf-Bushehr 波斯湾布什尔地区脆星粗毒的体外和计算机抗胆碱酯酶活性

Iranian South Medical Journal

Pub Date : 2022-12-01 DOI: 10.52547/ismj.25.4.297

H. Dehghani, Marzeah Rashedinia, G. Mohebbi, A. Vazirizadeh, Amar Maryamabadi, A. Barmak

引用次数: 0

Impact of Various Image Reconstruction Methods on Joint Compensation of Respiratory Motion and Partial Volume Effects in Whole-Body 18F-FDG PET/CT Imaging: Patients with Non-Small Cell Lung Cancer 不同图像重建方法对非小细胞肺癌癌症患者全身18F-FDG PET/CT成像呼吸运动和部分体积效应的联合补偿的影响

Iranian South Medical Journal

Pub Date : 2022-12-01 DOI: 10.52547/ismj.25.4.355

P. Ghafarian, Sahar Rezaei, E. Gharepapagh, Saeid Sarkar, M. Ay

引用次数: 0

Ethnopharmacology of Medicinal Plants in the North and West of Dashtestan County, Bushehr 布什尔Dashtestan县北部和西部药用植物的民族药理学

Iranian South Medical Journal

Pub Date : 2022-12-01 DOI: 10.52547/ismj.25.4.371

Z. khazaei, K. Vahdat, I. Nabipour

引用次数: 0

Nuclear Radiation and Thyroid Cancer; A Systematic Review 核辐射与甲状腺癌;系统回顾

Iranian South Medical Journal

Pub Date : 2022-09-01 DOI: 10.52547/ismj.25.3.261

A. Bolkheir, A. Ostovar, Maryam Moradinasab, B. Larijani

引用次数: 0

A Case of Systemic Lupus Erythematosus with Renal Failure Following the Administration of Sinopharm COVID-19 Vaccine 国药集团新冠肺炎疫苗接种后系统性红斑狼疮合并肾功能衰竭1例

Iranian South Medical Journal

Pub Date : 2022-09-01 DOI: 10.52547/ismj.25.3.277

M. Mahmudpour, I. Nabipour, A. Esmailie, A. Amini

The outbreak of COVID-19 has been revealed some pathogenic mechanisms which are indicating the role of virus in the pathogenesis of diseases such as diabetes mellitus, autoimmune and cardiovascular diseases. COVID-19 results in deterioration of glycemic control in diabetic patients and even in some cases developed new onset diabetes mellitus which are indicating the possible interfering role of SARS-CoV-2 in different metabolic pathways. Furthermore, during COVID-19 exacerbation of inactivated or de novo autoimmune diseases have been reported which indicate the causative role of virus in the stimulation of immune system and aggravation of autoimmune diseases through different mechanisms. In this report, a 31 year old male case of systemic lupus erythematosus (SLE) has been introduced who developed flu like illness, generalized edema and renal failure following the administration of third dose of Sinopharm BIBP COVID-19 (Sinopharm Beijing institute of Biological Products, China). During hospital course, proper therapeutic response was not achieved despite biopsy proven class IV lupus nephritis and standard therapy with methyl prednisolone and cyclophosphamide. He discharged with administration of routine hemodialysis thrice weekly. According to the course of disease, findings of biopsy and serologic tests, there were some challenging scenarios that are discussed in this report. © 2022, Bushehr University of Medical Sciences. All rights reserved.

新冠肺炎疫情的爆发揭示了病毒在糖尿病、自身免疫性疾病和心血管疾病等疾病发病机制中的作用。新冠肺炎导致糖尿病患者血糖控制恶化，部分患者甚至出现新发糖尿病，提示SARS-CoV-2可能在不同代谢途径中发挥干扰作用。此外，在COVID-19加重期间，已有灭活或新生自身免疫性疾病的报道，这表明病毒在刺激免疫系统和加重自身免疫性疾病中的致病作用通过不同的机制。本报告介绍了一例31岁男性系统性红斑狼疮(SLE)患者，在服用第三剂国药BIBP COVID-19(中国国药北京生物制品研究所)后出现流感样疾病、全身性水肿和肾功能衰竭。在住院期间，尽管活检证实为IV级狼疮肾炎，并使用甲基强的松龙和环磷酰胺进行标准治疗，但仍未达到适当的治疗反应。出院时给予每周三次常规血液透析。根据病程、活检和血清学检查的结果，本报告讨论了一些具有挑战性的情况。©2022，布什尔医学科学大学。版权所有。

{"title":"A Case of Systemic Lupus Erythematosus with Renal Failure Following the Administration of Sinopharm COVID-19 Vaccine","authors":"M. Mahmudpour, I. Nabipour, A. Esmailie, A. Amini","doi":"10.52547/ismj.25.3.277","DOIUrl":"https://doi.org/10.52547/ismj.25.3.277","url":null,"abstract":"The outbreak of COVID-19 has been revealed some pathogenic mechanisms which are indicating the role of virus in the pathogenesis of diseases such as diabetes mellitus, autoimmune and cardiovascular diseases. COVID-19 results in deterioration of glycemic control in diabetic patients and even in some cases developed new onset diabetes mellitus which are indicating the possible interfering role of SARS-CoV-2 in different metabolic pathways. Furthermore, during COVID-19 exacerbation of inactivated or de novo autoimmune diseases have been reported which indicate the causative role of virus in the stimulation of immune system and aggravation of autoimmune diseases through different mechanisms. In this report, a 31 year old male case of systemic lupus erythematosus (SLE) has been introduced who developed flu like illness, generalized edema and renal failure following the administration of third dose of Sinopharm BIBP COVID-19 (Sinopharm Beijing institute of Biological Products, China). During hospital course, proper therapeutic response was not achieved despite biopsy proven class IV lupus nephritis and standard therapy with methyl prednisolone and cyclophosphamide. He discharged with administration of routine hemodialysis thrice weekly. According to the course of disease, findings of biopsy and serologic tests, there were some challenging scenarios that are discussed in this report. © 2022, Bushehr University of Medical Sciences. All rights reserved.","PeriodicalId":14583,"journal":{"name":"Iranian South Medical Journal","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45683647","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Musculoskeletal Disorders (MSDS) in the Administrative Staff of the National Iranian Gas Transmission Company-District 9 (NIGTC-D9) 伊朗国家天然气输送公司第9区(NIGTC-D9)行政人员的肌肉骨骼疾病(MSDS)

Iranian South Medical Journal

Pub Date : 2022-09-01 DOI: 10.52547/ismj.25.3.250

M. A. Mououdi, Arezoo Sammak Amani, Kievan Ghezelbash, M. Ghahari, Tahmeineh Kebriyaee Nasab

引用次数: 0

下一页尾页

类型

全部化学•材料生命科学医学物理工程技术环境•农林材料科学地球科学法学管理学化学环境科学与生态学计算机科学教育学经济学农林科学人文科学生物学数学物理与天体物理心理学综合性期刊其他工业工程理学历史学农学文学信息工程

数据库

全部 ACS Publications Elsevier ieeexplore Springer The Royal Society of Chemistry Wiley

期刊

Iranian South Medical Journal

全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.

﹀